Cellectar Biosciences IncNASDAQ:CLRB
- LAST PRICE3.0200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.0300/ 27
- Ask / Lots3.0500/ 2
- Open / Previous Close3.0700 / 3.0200
- Day Range
- 52 Week Range
- Volume690,802
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CLRB |
|---|---|---|
| 09:32 ET | 48174 | 3.05 |
| 09:34 ET | 7433 | 3.01 |
| 09:36 ET | 1105 | 3.0183 |
| 09:38 ET | 18372 | 2.9672 |
| 09:39 ET | 23659 | 3 |
| 09:41 ET | 6349 | 2.97 |
| 09:43 ET | 500 | 3 |
| 09:45 ET | 3939 | 3 |
| 09:48 ET | 300 | 3.01 |
| 09:50 ET | 2115 | 2.995 |
| 09:52 ET | 1200 | 3.01 |
| 09:54 ET | 2739 | 3.0001 |
| 09:56 ET | 3999 | 2.9893 |
| 09:57 ET | 3000 | 2.985 |
| 09:59 ET | 3218 | 2.99 |
| 10:01 ET | 19366 | 2.9452 |
| 10:03 ET | 15040 | 2.9681 |
| 10:06 ET | 3938 | 2.9887 |
| 10:08 ET | 7699 | 2.975 |
| 10:10 ET | 499 | 2.978 |
| 10:12 ET | 8544 | 2.9722 |
| 10:14 ET | 11715 | 3.01 |
| 10:15 ET | 3739 | 3.0095 |
| 10:17 ET | 8346 | 3.02 |
| 10:19 ET | 7357 | 3.01 |
| 10:21 ET | 1346 | 3.0009 |
| 10:24 ET | 350 | 3.0013 |
| 10:26 ET | 1555 | 3.0011 |
| 10:28 ET | 3672 | 3.01 |
| 10:30 ET | 7456 | 3.02 |
| 10:32 ET | 7743 | 3 |
| 10:33 ET | 16864 | 2.9728 |
| 10:35 ET | 9718 | 2.9702 |
| 10:37 ET | 9246 | 2.96 |
| 10:39 ET | 14129 | 2.9793 |
| 10:42 ET | 1357 | 2.96 |
| 10:44 ET | 21758 | 2.98 |
| 10:46 ET | 1618 | 2.9975 |
| 10:50 ET | 12420 | 2.9849 |
| 10:55 ET | 100 | 2.99 |
| 10:57 ET | 100 | 3 |
| 11:00 ET | 200 | 3 |
| 11:02 ET | 604 | 3 |
| 11:06 ET | 800 | 3.01 |
| 11:08 ET | 100 | 3.02 |
| 11:09 ET | 200 | 3.02 |
| 11:11 ET | 2315 | 3.0125 |
| 11:13 ET | 5996 | 3.02 |
| 11:15 ET | 2079 | 3 |
| 11:18 ET | 850 | 3.0092 |
| 11:20 ET | 1500 | 3.0169 |
| 11:22 ET | 976 | 3.02 |
| 11:24 ET | 300 | 3.03 |
| 11:26 ET | 2100 | 3.03 |
| 11:27 ET | 8658 | 3.0101 |
| 11:29 ET | 2593 | 3 |
| 11:31 ET | 2800 | 2.9999 |
| 11:33 ET | 1031 | 2.99 |
| 11:36 ET | 100 | 3 |
| 11:38 ET | 170 | 2.99 |
| 11:40 ET | 100 | 3 |
| 11:42 ET | 100 | 2.99 |
| 11:44 ET | 3952 | 3 |
| 11:45 ET | 318 | 3 |
| 11:47 ET | 300 | 3.0099 |
| 11:49 ET | 1100 | 3.005 |
| 11:51 ET | 7380 | 3.02 |
| 11:54 ET | 1350 | 3.01 |
| 11:56 ET | 2500 | 3.0098 |
| 12:00 ET | 100 | 3.01 |
| 12:02 ET | 2700 | 3.02 |
| 12:05 ET | 5499 | 3.03 |
| 12:14 ET | 681 | 3.025 |
| 12:16 ET | 16840 | 3.03 |
| 12:18 ET | 13363 | 3.05 |
| 12:21 ET | 100 | 3.055 |
| 12:25 ET | 6300 | 3.05 |
| 12:30 ET | 100 | 3.06 |
| 12:34 ET | 100 | 3.058 |
| 12:38 ET | 250 | 3.059 |
| 12:39 ET | 16340 | 3.055 |
| 12:41 ET | 250 | 3.055 |
| 12:43 ET | 100 | 3.06 |
| 12:45 ET | 3737 | 3.065 |
| 12:48 ET | 742 | 3.08 |
| 12:50 ET | 800 | 3.1 |
| 12:52 ET | 5252 | 3.09 |
| 12:54 ET | 1290 | 3.095 |
| 12:56 ET | 1366 | 3.1 |
| 12:57 ET | 2050 | 3.1 |
| 01:01 ET | 1853 | 3.085 |
| 01:03 ET | 600 | 3.085 |
| 01:06 ET | 111 | 3.089 |
| 01:10 ET | 1000 | 3.08 |
| 01:12 ET | 1900 | 3.07 |
| 01:14 ET | 1450 | 3.07 |
| 01:19 ET | 1425 | 3.075 |
| 01:24 ET | 200 | 3.08 |
| 01:26 ET | 200 | 3.08 |
| 01:28 ET | 100 | 3.08 |
| 01:32 ET | 2276 | 3.0887 |
| 01:33 ET | 150 | 3.085 |
| 01:35 ET | 537 | 3.09 |
| 01:37 ET | 100 | 3.09 |
| 01:39 ET | 1983 | 3.095 |
| 01:44 ET | 200 | 3.1 |
| 01:46 ET | 1728 | 3.085 |
| 01:48 ET | 401 | 3.1 |
| 01:50 ET | 200 | 3.0952 |
| 01:53 ET | 300 | 3.095 |
| 02:00 ET | 2790 | 3.09 |
| 02:02 ET | 400 | 3.09 |
| 02:04 ET | 100 | 3.0885 |
| 02:08 ET | 300 | 3.08 |
| 02:09 ET | 100 | 3.08 |
| 02:11 ET | 110 | 3.0751 |
| 02:15 ET | 1276 | 3.075 |
| 02:18 ET | 5200 | 3.0701 |
| 02:20 ET | 100 | 3.07 |
| 02:22 ET | 2100 | 3.08 |
| 02:24 ET | 100 | 3.08 |
| 02:26 ET | 300 | 3.075 |
| 02:29 ET | 402 | 3.07 |
| 02:31 ET | 200 | 3.055 |
| 02:33 ET | 900 | 3.0501 |
| 02:40 ET | 16095 | 3.05 |
| 02:44 ET | 200 | 3.045 |
| 02:47 ET | 100 | 3.05 |
| 02:49 ET | 4699 | 3.06 |
| 02:51 ET | 600 | 3.06 |
| 02:54 ET | 300 | 3.06 |
| 02:56 ET | 1600 | 3.07 |
| 02:58 ET | 300 | 3.07 |
| 03:00 ET | 100 | 3.07 |
| 03:03 ET | 523 | 3.08 |
| 03:09 ET | 6318 | 3.0603 |
| 03:12 ET | 13397 | 3.065 |
| 03:14 ET | 100 | 3.07 |
| 03:16 ET | 6019 | 3.05 |
| 03:18 ET | 3150 | 3.055 |
| 03:20 ET | 15327 | 3.04 |
| 03:21 ET | 6930 | 3.0388 |
| 03:27 ET | 1900 | 3.04 |
| 03:30 ET | 2157 | 3.03 |
| 03:32 ET | 400 | 3.04 |
| 03:34 ET | 2877 | 3.0401 |
| 03:36 ET | 1300 | 3.0409 |
| 03:38 ET | 100 | 3.05 |
| 03:39 ET | 2491 | 3.03 |
| 03:43 ET | 7994 | 3.011 |
| 03:45 ET | 5510 | 3.02 |
| 03:48 ET | 225 | 3.02 |
| 03:50 ET | 600 | 3.025 |
| 03:52 ET | 600 | 3.02 |
| 03:54 ET | 1950 | 3.0201 |
| 03:56 ET | 7400 | 3.0261 |
| 03:57 ET | 8799 | 3.015 |
| 03:59 ET | 16327 | 3.02 |
Mar 28, 2024
DJ Cellectar Biosciences Is Maintained at Buy by Roth MKM, from 1:13PM ET on Thursday Mar 28, 2024 by Dow Jones
1:13PM ET on Thursday Mar 28, 2024 by Dow JonesDJ Cellectar Biosciences Price Target Raised to $12.00/Share From $11.00 by Oppenheimer, from 7:43AM ET on Thursday Mar 28, 2024 by Dow Jones
7:43AM ET on Thursday Mar 28, 2024 by Dow Jones
Mar 27, 2024
Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update, from 6:40AM ET on Wednesday Mar 27, 2024 by Dow Jones
6:40AM ET on Wednesday Mar 27, 2024 by Dow JonesPress Release: Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update, from 6:40AM ET on Wednesday Mar 27, 2024 by Dow Jones
6:40AM ET on Wednesday Mar 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cellectar Biosciences Inc | 98.7M | -0.9x | --- |
Zhong Yuan Bio-Technology Holdings Ltd | 88.4M | 392.2x | --- |
Hongchang International Co Ltd | 115.5M | -258.8x | --- |
Spectral Medical Inc | 86.4M | -8.2x | --- |
Odonate Inc | 50.0M | -1,384.3x | --- |
Biostem Technologies Inc | 126.0M | 0.0x | --- |
Company Information
Cellectar Biosciences, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The Company, through phospholipid ether drug conjugate (PDC) delivery platform, is focused on developing PDCs that are designed to specifically target cancer cells. Its PDC platform possesses the potential for the discovery and development of cancer-targeting treatments, and it plans to develop PDCs both independently and through research and development collaborations. Its product pipeline includes iopofosine, a small-molecule PDC designed to provide targeted delivery of iodine-131 (radioisotope), preclinical PDC chemotherapeutic programs and multiple partnered PDC assets. Its Iopofosine is evaluated in the completed CLOVER-WaM Phase 2 pivotal study in patients with relapsed/refractory (r/r) Waldenstrom’s macroglobulinemia (WM).
Contact Information
- Headquarters
- 100 Campus DriveFLORHAM PARK, NJ, United States 07932
- Phone
- 608-441-8120
- Fax
- 608-441-8121
Executives
- Independent Director
- Douglas Swirsky
- President, Chief Executive Officer, Director
- James Caruso
- Chief Financial Officer, Vice President, Secretary
- Chad Kolean
- Chief Operating Officer
- Jarrod Longcor
- Senior Vice President - Medical
- Andrei Shustov
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $97.4M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 32.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.99 |
EPS | $-3.20 |
Book Value | $-0.07 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
